Gilead Sciences, Inc. today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference on Retroviruses ...

Otherwise, it would lead to diseases like acute (sudden) hepatitis (inflammation), chronic (long duration) hepatitis, fatty ...

Several studies have suggested that COVID-19 may increase a person’s risk of developing cancer or promote metastasis of existing cancer.

Learn more about whether Ionis Pharmaceuticals, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

Michelle Trachtenberg died at age 39 on Feb. 26 and her cause of death has been labeled "undetermined" as her family objected ...

Here, Zhuang et al. analyse a decade of surveillance data (2007–2017) from Dongtai, China, and estimate HEV 239 effectiveness of 72% amongst hepatitis B virus infected people.

Hepatitis E, tetanus and hepatitis B all pose significant but under-reported threats to the health and lives of women and girls, especially in low-income countries with limited access to healthcare.

From the column: "Health care providers are battling the storm, on a seemingly impossible quest to repair the tattered mess ...

ADMA Biologics (NASDAQ:ADMA – Get Free Report)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a report released on Tuesday,Benzinga reports. They currently have a ...

France warned Wednesday against dietary supplements promising weight loss that use the tropical plant Garcinia cambogia after ...

New York State Common Retirement Fund lowered its stake in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 4.5% during ...